Clinical Research Directory

Effect of Psiguavin for Obesity Treatment (PSIGUAVIN)

Sponsor: Universidad Católica San Antonio de Murcia

Summary

The main objective of the project focuses on the study of the effectiveness of a functional component extracted from Psidium guava, psiguavin, as a potential inhibitor of pancreatic lipase and, therefore, as an adjuvant for the treatment of obesity. That is, the aim is to verify from various experimental perspectives the effect of psiguavin on the activity of the enzyme pancreatic lipase (EC 3.1.1.3), which is the main enzyme responsible for the digestion of lipids from the diet. Our preliminary studies have shown that there is a strong interaction between psiguavin and the active center of pancreatic lipase; however, it is necessary to confirm these initial hypotheses through a clinical trial. Taking into account that the usefulness of this compound is based on the reduction of dietary calorie intake, in order to confirm its therapeutic usefulness, a clinical trial will be proposed. To this end, the following specific objective is defined, which is intended to be achieved with the execution of the project: • Evaluate the effect of psiguavin on weight loss of people with overweight/obese people.

Official title: Effect of Psiguavin, a Bioactive Compound Derived From Psidium Guava, as Therapeutic Agent for Obesity Treatment

Key Details

Conditions

Interventions

Locations (1)